Anticoagulant Policy Term Definition

any agent used to prevent the formation of blood clots. This class of medications is used for the prophylaxis and/or treatment of thromboembolic disorders and for these clinical purposes include:

  • Injectable anticoagulants including unfractionated heparin, low molecular weight heparin (i.e. Lovenox), direct thromin inhibitors (i.e. Argatroban, Bivalirudin) ad Factor Xa inhibitors (i.e., Fondaparinux) and
  • Oral anticoagulants such as warfarin